China's growth and its implications
Vanguard's proprietary measure reflects volatility in growth that doesn't appear in official GDP numbers.
For now, policy remains a tailwind
Amid hope that COVID-19 vaccines drive immunity and enliven economic activity, investors are starting to wonder what happens when 'whatever it takes' fiscal and monetary policy gives way to an unwinding of bold actions. But that may not happen anytime soon.
COVID-19 vaccine rollout and the economy
The pace of vaccinations holds the key to achieving COVID-19 herd immunity and to economic recovery.
Emerging-market debt: Finding value in a time of pandemic
Vanguard's emerging markets credit team believes opportunities to add value exist even in this rapidly evolving fiscal environment.
Quantifying the future of remote work
A Vanguard analysis finds that about 15% of all U.S. jobs can permanently be performed remotely.
A pandemic, a vaccine, and a sea of ideas
We're not surprised that a COVID-19 vaccine came this far so quickly. It was a decade of idea-sharing in the making.
Investment-grade corporate credit and the pandemic
With initial credit market adjustments to the pandemic behind us, Vanguard's credit analysts outline further opportunities for active management to add value, including within some of the more COVID-affected sectors.
Envisioning a post-pandemic future
The COVID-19 pandemic has accelerated some trends already in place, and it will have additional implications that are opaque now but that will become undeniably clear and meaningful over time.
Hear directly from Vanguard leaders on topics you care about
Vanguard Voices™